Drawing for VIRCONET

USPTO serial 76013546

VIRCONET

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LEIPZIG, MARC J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIRCONET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Raymond C. Stewart

RAYMOND C STEWART BIRCH, STEWART, KOLASCH & BIRCH, LLPP O BOX 747FALLS CHURCH, VA 22040-0747UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer software for entering, processing and generating biological test data and results; computer software for entering, processing and generating therapeutic drug screening and therapeutic drug testing data and results; computer software for entering, processing and generating medical, clinical patient and research data and results, computer software for entering, processing and generating diagnostic and laboratory data and results; pre-recorded magnetic data carriers and compact discs containing computer software for entering, processing and generating biological test data and results, therapeutic drug screening and therapeutic drug testing data and results, computer software for entering, processing and generating medical, clinical patient and research data and results, and computer software for entering, processing and generating diagnostic and laboratory data and resultsACTIVE—
042Medical care; biological research; clinical medical research; medical services, namely managing treatment of patients undergoing chemotherapy; therapeutic drug screening and therapeutic drug testing programs; diagnostic laboratory research services in the fields of microbiology, virology, oncology and metabolic disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 28, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 8, 2003EX1GSOU EXTENSION 1 GRANTED—
Jan 15, 2003EXT1SOU EXTENSION 1 FILED—
Jan 15, 2003MAILPAPER RECEIVED—
Jul 16, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 23, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 3, 2002NPUBNOTICE OF PUBLICATION—
Aug 29, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 26, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 20, 2000DOCKASSIGNED TO EXAMINER—
Sep 14, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance